Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival: a Randomized Controlled Trial

NCT07731425 is registered in ClinicalTrials.gov with London School of Economics and Political Science as lead sponsor.

NCT NCT07731425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07731425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival: a Randomized Controlled Trial
Lead sponsor
London School of Economics and Political Science
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
October 1, 2026
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer